Sonoma Pharmaceuticals, Inc. (SNOA)
1.22
-0.01
(-0.81%)
USD |
NASDAQ |
Oct 07, 16:00
1.19
-0.03
(-2.46%)
After-Hours: 20:00
Sonoma Pharmaceuticals Net Income (Quarterly) : -0.33M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.33M |
| March 31, 2026 | -0.581M |
| December 31, 2025 | -0.819M |
| September 30, 2025 | -0.534M |
| June 30, 2025 | -1.241M |
| March 31, 2025 | -0.776M |
| December 31, 2024 | -0.928M |
| September 30, 2024 | -0.61M |
| June 30, 2024 | -1.143M |
| March 31, 2024 | -1.067M |
| December 31, 2023 | -0.866M |
| September 30, 2023 | -1.484M |
| June 30, 2023 | -1.418M |
| March 31, 2023 | -1.308M |
| December 31, 2022 | -1.939M |
| September 30, 2022 | -1.017M |
| June 30, 2022 | -0.887M |
| March 31, 2022 | -2.944M |
| December 31, 2021 | -0.944M |
| September 30, 2021 | -0.10M |
| June 30, 2021 | -1.098M |
| March 31, 2021 | -3.432M |
| December 31, 2020 | -0.626M |
| September 30, 2020 | 0.151M |
| June 30, 2020 | -0.709M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.749M |
| December 31, 2019 | -1.21M |
| September 30, 2019 | -1.288M |
| June 30, 2019 | 0.674M |
| March 31, 2019 | -3.222M |
| December 31, 2018 | -2.298M |
| September 30, 2018 | -2.82M |
| June 30, 2018 | -3.458M |
| March 31, 2018 | -4.763M |
| December 31, 2017 | -3.187M |
| September 30, 2017 | -2.87M |
| June 30, 2017 | -3.508M |
| March 31, 2017 | -2.929M |
| December 31, 2016 | 0.763M |
| September 30, 2016 | -2.639M |
| June 30, 2016 | -3.187M |
| March 31, 2016 | -2.91M |
| December 31, 2015 | -3.149M |
| September 30, 2015 | -1.763M |
| June 30, 2015 | -2.34M |
| March 31, 2015 | -1.502M |
| December 31, 2014 | -5.914M |
| September 30, 2014 | -0.718M |
| June 30, 2014 | -0.07M |
| March 31, 2014 | 7.457M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 6.406M |
| Total Expenses (Quarterly) | 6.736M |
| EPS Diluted (Quarterly) | -0.0858 |
| Enterprise Value | 1.240M |
| Gross Profit Margin (Quarterly) | 40.23% |
| Profit Margin (Quarterly) | -5.15% |
| Earnings Yield | -99.80% |
| Normalized Earnings Yield | -99.80 |